These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33973385)

  • 1. Body Composition in Patients With Psoriatic Arthritis and Changes During Interleukin-12/Interleukin-23 Inhibition.
    Paccou J; Bavière W; Sornay-Rendu E; Szulc P; Ramdane N; Cortet B; Chapurlat R; Flipo RM
    Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1608-1613. PubMed ID: 33973385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis.
    Tournadre A; Pereira B; Dutheil F; Giraud C; Courteix D; Sapin V; Frayssac T; Mathieu S; Malochet-Guinamand S; Soubrier M
    J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):639-646. PubMed ID: 28316139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New onset or transition of disease state of psoriatic arthritis during treatment with ustekinumab: A single-center retrospective study.
    Asahina A; Umezawa Y; Momose M; Honda H; Yanaba K; Nakagawa H
    J Dermatol; 2017 Dec; 44(12):1380-1384. PubMed ID: 28771778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study.
    Araujo EG; Englbrecht M; Hoepken S; Finzel S; Kampylafka E; Kleyer A; Bayat S; Schoenau V; Hueber A; Rech J; Schett G
    Semin Arthritis Rheum; 2019 Feb; 48(4):632-637. PubMed ID: 30037432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis.
    Pedreira PG; Pinheiro MM; Szejnfeld VL
    Arthritis Res Ther; 2011 Feb; 13(1):R16. PubMed ID: 21299865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriatic arthritis is associated with adverse body composition predictive of greater coronary heart disease and type 2 diabetes propensity - a cross-sectional study.
    Ferguson LD; Linge J; Dahlqvist Leinhard O; Woodward R; Hall Barrientos P; Roditi G; Radjenovic A; McInnes IB; Siebert S; Sattar N
    Rheumatology (Oxford); 2021 Apr; 60(4):1858-1862. PubMed ID: 33147607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results.
    Smolen JS; Siebert S; Korotaeva TV; Selmi C; Bergmans P; Gremese E; Joven-Ibáñez B; Katsifis G; Noël W; Nurmohamed MT; Richette P; Sfikakis PP; de Vlam K; Theander E; Gossec L
    Ann Rheum Dis; 2021 Nov; 80(11):1419-1428. PubMed ID: 34162594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison.
    Letarouilly JG; Flachaire B; Labadie C; Kyheng M; Cohen N; Sellam J; Richette P; Dieude P; Claudepierre P; Fautrel B; Houvenagel E; Nguyen CD; Guyot MH; Segaud N; Marguerie L; Deprez X; Salmon JH; Baudens G; Miceli-Richard C; Gervais E; Chary-Valckenaere I; Lafforgue P; Philippe P; Loeuille D; Richez C; Tubach F; Pham T; Flipo RM
    Rheumatology (Oxford); 2021 Jun; 60(6):2773-2782. PubMed ID: 33232465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of ustekinumab in patients with psoriatic arthritis in a real-world, multicenter study.
    Azuaga AB; Frade-Sosa B; Laiz A; Estrada P; Prior-Español A; Horcada L; Polino L; Moreno M; Moragues C; Urruticoechea-Arana A; Sellas A; Tandaipan JL; Torrente-Segarra V; Garcia-Miguel J; Ros I; Ordoñez S; Moya P; Reina D; Mateo-Soria L; Fito C; Beltrán E; Pujol M; Cuervo AM; Cañete JD; Ramírez J;
    Clin Rheumatol; 2020 Oct; 39(10):2963-2971. PubMed ID: 32285259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE).
    Iannone F; Santo L; Bucci R; Semeraro A; Carlino G; Paoletti F; Quarta L; Leucci P; Zuccaro C; Marsico A; Scioscia C; D'Onofrio F; Mazzotta D; Muratore M; Cantatore FP; Lapadula G
    Clin Rheumatol; 2018 Mar; 37(3):667-675. PubMed ID: 29411182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum C-reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: Long-term differential effects of biologics.
    Asahina A; Umezawa Y; Yanaba K; Nakagawa H
    J Dermatol; 2016 Jul; 43(7):779-84. PubMed ID: 26704718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body composition changes in stable-weight elderly subjects: the effect of sex.
    Zamboni M; Zoico E; Scartezzini T; Mazzali G; Tosoni P; Zivelonghi A; Gallagher D; De Pergola G; Di Francesco V; Bosello O
    Aging Clin Exp Res; 2003 Aug; 15(4):321-7. PubMed ID: 14661824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients.
    Galluzzo M; D'Adamio S; Pastorino R; Andreoli A; Servoli S; Bianchi L; Talamonti M
    Expert Opin Biol Ther; 2018 Mar; 18(3):229-235. PubMed ID: 29252034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study.
    Napolitano M; Costa L; Caso F; Megna M; Scarpa R; Balato N; Ayala F; Balato A
    Clin Rheumatol; 2017 Jul; 36(7):1589-1593. PubMed ID: 28567556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of a structured weight-loss treatment on physical fitness in patients with psoriatic arthritis and obesity compared to matched controls: a prospective interventional study.
    Bilberg A; Larsson I; Björkman S; Eliasson B; Klingberg E
    Clin Rheumatol; 2022 Sep; 41(9):2745-2754. PubMed ID: 35648298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher bodily adiposity, fat intake, and cholesterol serum levels are associated with higher disease activity in psoriatic arthritis patients: is there a link among fat and skin and joint involvement?
    Leite BF; Morimoto MA; Gomes C; Klemz BNC; Genaro PS; Damasceno NRT; Szejnfeld VL; Pinheiro MM
    Lipids Health Dis; 2020 Feb; 19(1):21. PubMed ID: 32028959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal Disease Activity and Patient-Acceptable Symptom State in Psoriatic Arthritis: A Real-World Evidence Study With Ustekinumab.
    Queiro R; Brandy A; Rosado MC; Lorenzo A; Coto P; Carriles C; Alperi M; Ballina J
    J Clin Rheumatol; 2018 Oct; 24(7):381-384. PubMed ID: 29509560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition and clinical symptoms in patients with hip or knee osteoarthritis: Results from the KHOALA cohort.
    Jeanmaire C; Mazières B; Verrouil E; Bernard L; Guillemin F; Rat AC
    Semin Arthritis Rheum; 2018 Jun; 47(6):797-804. PubMed ID: 29224976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in body composition and bone mineral density in postmenopausal women with psoriatic arthritis.
    Krajewska-Włodarczyk M; Owczarczyk-Saczonek A; Placek W
    Reumatologia; 2017; 55(5):215-221. PubMed ID: 29332959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis.
    Zabotti A; Goletti D; Lubrano E; Cantini F
    Expert Opin Drug Saf; 2020 Jan; 19(1):69-82. PubMed ID: 31847608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.